EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure

NCT00338000 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

292

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Renal Failure

Interventions

DRUG: Epoetin alfa

Sponsor

Janssen Pharmaceutica N.V., Belgium